18th December 2024, Anand
ICAR-Directorate of Medicinal and Aromatic Plants Research has been granted an Indian Patent (Patent No. 556149) for the development of a novel drug formulation using Kalmegh (Andrographis paniculata). The patented formulation, entitled ‘Development of microencapsulated formulation based on Andrographolide and Method of Preparation,’ improves the bioavailability and sustained release of Andrographolide, the active compound in Kalmegh, for enhanced therapeutic efficacy.
Dr Manish Das, Director, ICAR-DMAPR, highlighted that the microencapsulated formulation is expected to have greater demand in the pharmaceutical industry due to its enhanced properties.
Kalmegh, a key crop of ICAR-DMAPR, is widely used in Ayurveda for treating ailments like diabetes, bronchitis, jaundice, fever, and skin diseases. The patented technology offers significant benefits in pharmaceutical applications, with improved bioavailability making it an attractive option for the industry.
The technology was developed by Dr Narendra A. Gajbhiye and Jitendra Kumar of ICAR-DMAPR.
(Source: ICAR-Directorate of Medicinal and Aromatic Plants Research, Anand, Gujarat)
Like on Facebook
Subscribe on Youtube
Follow on X X
Like on instagram